Mayflower Financial Advisors LLC Has $879,000 Position in Colgate-Palmolive (NYSE:CL)

Mayflower Financial Advisors LLC reduced its stake in shares of Colgate-Palmolive (NYSE:CL) by 8.6% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,057 shares of the company’s stock after selling 855 shares during the quarter. Mayflower Financial Advisors LLC’s holdings in Colgate-Palmolive were worth $879,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of CL. Main Street Research LLC raised its position in Colgate-Palmolive by 1.5% in the 2nd quarter. Main Street Research LLC now owns 6,939 shares of the company’s stock valued at $673,000 after buying an additional 100 shares during the last quarter. BLB&B Advisors LLC raised its position in Colgate-Palmolive by 2.5% in the 2nd quarter. BLB&B Advisors LLC now owns 4,337 shares of the company’s stock valued at $421,000 after buying an additional 104 shares during the last quarter. ZWJ Investment Counsel Inc. raised its position in Colgate-Palmolive by 3.1% in the 2nd quarter. ZWJ Investment Counsel Inc. now owns 3,591 shares of the company’s stock valued at $349,000 after buying an additional 109 shares during the last quarter. Hexagon Capital Partners LLC raised its position in Colgate-Palmolive by 9.5% in the 2nd quarter. Hexagon Capital Partners LLC now owns 1,274 shares of the company’s stock valued at $124,000 after buying an additional 110 shares during the last quarter. Finally, RFG Advisory LLC raised its position in Colgate-Palmolive by 2.1% in the 2nd quarter. RFG Advisory LLC now owns 5,411 shares of the company’s stock valued at $525,000 after buying an additional 112 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Performance

Shares of NYSE CL opened at $108.52 on Friday. The company has a debt-to-equity ratio of 16.90, a current ratio of 1.06 and a quick ratio of 0.70. The stock’s fifty day moving average price is $100.86 and its two-hundred day moving average price is $94.28. Colgate-Palmolive has a one year low of $67.62 and a one year high of $109.30. The firm has a market cap of $89.03 billion, a price-to-earnings ratio of 34.34, a P/E/G ratio of 3.73 and a beta of 0.39.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, July 26th. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The firm had revenue of $5.06 billion for the quarter, compared to analyst estimates of $5 billion. During the same period in the prior year, the firm posted $0.77 EPS. The company’s revenue for the quarter was up 4.9% on a year-over-year basis. On average, equities analysts forecast that Colgate-Palmolive will post 3.57 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Friday, July 19th were issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 1.84%. The ex-dividend date was Friday, July 19th. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 63.29%.

Insider Transactions at Colgate-Palmolive

In other news, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the sale, the director now directly owns 11,755 shares of the company’s stock, valued at approximately $1,220,874.30. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other news, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the sale, the director now directly owns 11,755 shares of the company’s stock, valued at approximately $1,220,874.30. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, EVP Gregory Malcolm sold 10,533 shares of the stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.10, for a total value of $1,085,952.30. Following the sale, the executive vice president now directly owns 10,377 shares in the company, valued at $1,069,868.70. The disclosure for this sale can be found here. In the last three months, insiders have sold 43,490 shares of company stock valued at $4,486,063. 0.34% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

CL has been the topic of several recent analyst reports. HSBC reaffirmed a “hold” rating on shares of Colgate-Palmolive in a research report on Friday, July 26th. Jefferies Financial Group lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and lowered their price target for the stock from $103.00 to $95.00 in a research report on Wednesday, July 24th. Wells Fargo & Company boosted their price target on Colgate-Palmolive from $92.00 to $97.00 and gave the stock an “equal weight” rating in a research report on Wednesday, July 10th. Deutsche Bank Aktiengesellschaft boosted their price target on Colgate-Palmolive from $104.00 to $107.00 and gave the stock a “buy” rating in a research report on Monday, July 29th. Finally, Redburn Atlantic raised Colgate-Palmolive to a “hold” rating in a research report on Thursday, August 1st. Eight analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $102.53.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.